At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
When Audiologists Lead, Patients Win
Level Up Your Practice at AAA 2026—Bring Your Assistant and Take Advantage of Exclusive Package Discounts! The Audiology Assistant Track is back by popular demand at AAA 2026,…
Utah Committee Removes Audiology Deregulation Language After Strong Professional Pushback
Early last week, the Utah Office of Professional Licensing Review (OPLR) released draft legislation proposing major revisions to the regulatory framework for licensure of multiple…
Academy Joins National Push for Inclusive Loan Rules for Health Professions
Late last month, the Academy signed onto a letter to the Department of Education and the Reimagining and Improving Student Education (RISE) rulemaking committee urging…


